The Adverse Drug Reaction (ADRe) Profile for Polypharmacy

NACompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

December 18, 2018

Primary Completion Date

May 31, 2019

Study Completion Date

December 31, 2020

Conditions
Polypharmacy
Interventions
OTHER

Adverse Drug Reaction ADRe Profile for Polypharmacy

PADRe asks nurses to systematically check patients for the manifestation of itemised adverse side effects or undesirable effects of their primary care medicines, as listed in the British National Formulary (BNF) and manufacturers' Summaries of Product Characteristics (SmPCs), and seminal texts documenting known ADRs. Nurses are asked to share the identified problems with prescribers and pharmacists overseeing medicines charts. A full description is published (references below).

Trial Locations (1)

sa2 8pp

Swansea University, Swansea

All Listed Sponsors
collaborator

Aneurin Bevan University Health Board

OTHER

collaborator

Cardiff University

OTHER

lead

Swansea University

OTHER

NCT03955133 - The Adverse Drug Reaction (ADRe) Profile for Polypharmacy | Biotech Hunter | Biotech Hunter